Lumagod, Prince Asher H.

HRN: 20-60-59  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/29/2022
11/05/2022
TOPICAL
1
QID
Mouth Sores
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: